Shares of Relx Plc (NYSE:RELX – Get Free Report) have earned an average rating of “Moderate Buy” from the nine brokerages that are covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation, five have issued a buy recommendation and one has given a strong buy recommendation to the company.
A number of research firms have issued reports on RELX. TD Cowen began coverage on shares of Relx in a research note on Thursday, September 10th. They set a “buy” rating for the company. Weiss Ratings upgraded shares of Relx from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, August 7th. TD Securities raised Relx to a “strong-buy” rating in a report on Friday, September 11th. Wall Street Zen downgraded Relx from a “buy” rating to a “hold” rating in a research report on Sunday, September 13th. Finally, Barclays reissued an “overweight” rating on shares of Relx in a report on Friday, July 24th.
Read Our Latest Stock Analysis on Relx
Institutional Inflows and Outflows
Relx Trading Up 0.9%
RELX stock opened at $33.48 on Friday. The company has a quick ratio of 0.40, a current ratio of 0.45 and a debt-to-equity ratio of 5.23. Relx has a fifty-two week low of $27.57 and a fifty-two week high of $47.22. The firm’s 50-day simple moving average is $35.03 and its 200 day simple moving average is $34.03.
Relx Cuts Dividend
The firm also recently declared a dividend, which was paid on Tuesday, September 15th. Shareholders of record on Friday, August 7th were given a dividend of $0.2785 per share. This is a drop from Relx’s previous dividend of $0.6559. The ex-dividend date was Friday, August 7th. This represents a yield of 157.0%.
About Relx
RELX plc is a global information and analytics company that provides specialized content, data, software, and decision-support tools to professional and business customers. Its products are designed to help customers work more efficiently, manage risk, conduct research, comply with regulations, and make informed decisions.
The company operates through several major business areas. Elsevier serves the scientific, technical, and medical markets with research journals, books, databases, and analytical tools.
Featured Stories
- Five stocks we like better than Relx
- Everyone in AI Is Quietly Copying Palantir’s Playbook
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
- JPMorgan Bets on Genius Sports as the Market Loses Patience
- Appleās $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.
